Tag archive for ‘Mylan’’
Shai Genish On Thursday, October 26th, 2017

The UK Court Overturned Teva’s Copaxone Patent

Facebook1 Twitter Google Plus0 Pinterest0 Email   The British Supreme Court ruled Thursday in favor of Mylan and its Dutch partner Synthon, and canceled all Teva’s Copaxone for 40 mg in the country based More...

Jewish Business News On Thursday, March 3rd, 2016

Perrigo Inaugurates $46 Million Factory in Israel

Facebook0 Twitter Google Plus0 Pinterest0 Email   Perrigo pharmaceutical firm opened a new factory in south of Israel, Reuters reports on Wednesday. The company invested some $45 million to expand its More...

(L-R) Robert J Coury, Mylan and Joseph Papa, Perrigo
Niva Goldberg On Thursday, October 22nd, 2015

Perrigo Taking Actions to Fend Off Mylan, Deliver Shareholder Value Far Superior to Mylan Offer

Facebook0 Twitter Google Plus0 Pinterest0 Email Perrigo, which is the target of a hostile takeover bid by Mylan, said Thursday that it would reduce its workforce by approximately 800 employees,  More...

(L-R) Robert J Coury, Mylan and Joseph Papa, Perrigo
Ilan Shavit On Tuesday, October 13th, 2015

Mylan to Pitch Today to Perrigo Shareholders in Hostile Takeover Bid

Facebook0 Twitter Google Plus0 Pinterest0 Email   The hostile takeover bid for Perrigo Co. PLC continues with Mylan NV hosting a Tuesday,  5 pm,  conference call to pitch the buyout to Perrigo shareholders. Perrigo More...

(L-R) Robert J Coury, Mylan and Joseph Papa, Perrigo
Niva Goldberg On Tuesday, September 15th, 2015

Mylan Begins $27 Billion Hostile Bid for Perrigo

Facebook0 Twitter Google Plus0 Pinterest0 Email   Mylan N.V. on Monday announced that it has officially took its $27 billion takeover bid directly to shareholders of Perrigo Company plc (NYSE: PRGO; TASE). In More...

(L-R) Robert J Coury, Mylan and Joseph Papa, Perrigo

Perrigo CEO: Mylan’s Propose Shows Sign of Desperation

Facebook0 Twitter Google Plus0 Pinterest0 Email   Perrigo Company plc (NYSE: PRGO; TASE) today responded to the announcement that Mylan N.V. has lowered the acceptance condition for its proposed unsolicited More...

Shiri Habib-Valdhorn On Thursday, August 13th, 2015

Mylan Might Make Do With Only 50% of Perrigo

Facebook0 Twitter Google Plus0 Pinterest0 Email   Generic pharmaceutical company Mylan N.V. (MYL) today officially announced a reduction in the approval requirement for the Perrigo Company (NYSE:PRGO; TASE:PRGO) More...

Shiri Habib-Valdhorn On Monday, July 27th, 2015

Three Way Takeover Battle – The End: Teva Losing $300 Million on Mylan Stake

Facebook0 Twitter Google Plus0 Pinterest0 Email   Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has officially announced that it is withdrawing its bid to buy generic pharmaceuticals rival More...

Niva Goldberg On Thursday, July 23rd, 2015

Three Ways Takeover Battle: Mylan Invokes “Poison Pill” To Block Teva Hostile Takeover

Facebook0 Twitter Google Plus0 Pinterest0 Email   Dutch Stichting Foundation notified Mylan that it has exercised its call option to acquire 488, 388, 431 Mylan preferred shares pursuant to the Call Option More...

Niva Goldberg On Thursday, July 16th, 2015

Mylan Battles Against Teva Takeover: US Consumer Groups Oppose Merger

Facebook0 Twitter Google Plus0 Pinterest0 Email “A takeover of Mylan by Teva is a bad deal for consumers, ” claim. US consumer organizations that have jointly written to the Federal Trade Commission More...

Email:

Delivered by FeedBurner